Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Hepatology

• Publication date

  1998-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/HEP.510270133PMID 9425940
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen

  1997cited by this paper
• Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization.

  1996cited by this paper
• Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis

  1996cited by this paper
• Hepatitis B virus surface mutations associated with infection after liver transplantation.

  1996cited by this paper
• Hepatitis B envelope protein mutants.

  1995cited by this paper
• Glycine-to-arginine substitution at codon 145 of HBsAg in two infants Born to hepatitis B e antigen-positive carrier

  1995cited by this paper
• Hepatitis B envelope protein mutants

  1995cited by this paper
• Mutations of some critical amino acid residues in the hepatitis B virus surface antigen

  1995cited by this paper
• A unique insertion in the S gene of surface antigen–negative hepatitis B virus Chinese carriers

  1995cited by this paper
• The stem-loop structure of the cis-encapsidation signal is highly conserved in naturally occurring hepatitis B virus variants.

  1994cited by this paper
• Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal.

  1994cited by this paper
• Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region

  1993cited by this paper
• Liver transplantation in European patients with the hepatitis B surface antigen.

  1993cited by this paper
• Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection

  1993cited by this paper
• Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen.

  1993cited by this paper
• Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody—treated liver transplant patients

  1992cited by this paper
• Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.

  1992cited by this paper
• Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus.

  1992cited by this paper
• Independent emergence of a vaccine-induced escape mutant of hepatitis B virus.

  1991cited by this paper
• Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization.

  1991cited by this paper
• Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease

  1991cited by this paper
• Liver transplantation for viral hepatitis.

  1990cited by this paper
• Vaccine-induced escape mutant of hepatitis B virus.

  1990cited by this paper
• Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. I. Region S(139-147).

  1990cited by this paper
• The antigenic index: a novel algorithm for predicting antigenic determinants

  1988cited by this paper
• Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr

  1987cited by this paper
• Antibody responses to recombinant and plasma derived hepatitis B vaccines.

  1986cited by this paper
• Hepatitis B surface antigen (HBsAg) subtype‐specific antibodies in persons vaccinated against hepatitis B

  1984cited by this paper
• Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant.

  1982cited by this paper
• Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection.

  1982cited by this paper

• Revisiting the Biological Rationale for Cytomegalovirus Immune Globulin (CMVIG) in the Modern Era of Solid Organ Transplantation: Current State and Future Direction.

  2025cites this paper
• Characteristics of hepatitis B virus surface protein and occult hepatitis B infection in infants with immunoprophylaxis failure from Indonesia.

  2025cites this paper
• HBV Recurrence Detected by HBV‐Related Serum Markers and Immune Escape Mutations in Chronic Hepatitis B Patients Following Liver Transplantation

  2025cites this paper
• Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies

  2023cites this paper
• Managing HBV and HCV Infection Pre- and Post-liver Transplant.

  2023cites this paper
• Establishment of monoclonal antibodies broadly neutralize infection of hepatitis B virus

  2022cites this paper
• Occult hepatitis B — the result of the host immune response interaction with different genomic expressions of the virus

  2022cites this paper
• Prevention of HBV Recurrence After Liver Transplant: Long-Term Results.

  2021cites this paper
• Occult Hepatitis B Virus Infection: A Comprehensive Review

  2021cites this paper
• Gga-miR-181a modulates ANP32A expression and inhibits MDCC-MSB-1 cell

  2021cites this paper
• 2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus‐related infection before and after liver transplantation

  2021cites this paper
• Persistence of Hepatitis B Virus Infection: A Multi-Faceted Player for Hepatocarcinogenesis

  2021cites this paper
• Mapping the conformational epitope of a therapeutic monoclonal antibody against HBsAg by in vivo selection of HBV escape variants

  2021cites this paper
• Multiple epitopes of hepatitis B virus surface antigen targeted by human plasma‐derived immunoglobulins coincide with clinically observed escape mutations

  2021cites this paper
• A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation

  2020cites this paper
• Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion

  2020cites this paper
• Biological Principles and Clinical Issues Underlying Liver Transplantation for Viral‐Induced End‐Stage Liver Disease in the Era of Highly Effective Direct‐Acting Antiviral Agents

  2020cites this paper
• Review article: preventing hepatitis B graft infection in hepatitis B patients after liver transplantation: immunoglobulin vs anti‐virals

  2020cites this paper
• Prevention of HBV Recurrence after Liver Transplant: A Review

  2020cites this paper
• Mutations and methods of analysis of mutations in Hepatitis B virus

  2020cites this paper
• Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of the KOTRY Database

  2020cites this paper
• Hepatitis B Immunoglobulin discontinuation in long‐term liver transplant patients

  2020influential citation
• Long‐term consequences of stopping HBIG and/or nucleotide analogues in liver transplant recipients administered hepatitis B vaccination to prevent HBV reinfection

  2019cites this paper
• Hepatitis B virus recurrence after living donor liver transplantation of anti-HBc-positive grafts: A 22-year experience at a single center.

  2019cites this paper
• Efficacy and safety of Niuliva® immune globulin to prevent hepatitis B reinfection in de novo orthotopic liver transplant

  2019cites this paper
• Assessment of patient safety and the efficiency of facility utilization following simplified ultra-rapid intravenous infusion of hepatitis B immunoglobulin in a high-volume liver transplantation center

  2019cites this paper
• © immune globulin to prevent hepatitis B reinfection in de novo orthotopic liver transplant

  2019cites this paper
• Deep sequencing of hepatitis B surface antigen gene in the preserved umbilical cords in immunoprophylaxis failure against mother-to-child HBV transmission

  2019cites this paper
• Determination of Hepatitis B Immunoglobulin Infusion Interval Using Pharmacokinetic Half-life Simulation for Posttransplant Hepatitis B Prophylaxis

  2019cites this paper
• Hepatitis B and liver transplantation

  2018cites this paper
• Hepatitis B virus infection: Defective surface antigen expression and pathogenesis

  2018cites this paper
• Quasispecies characters of hepatitis B virus in immunoprophylaxis failure infants

  2018cites this paper
• Impact of immune escape mutations and N-linked glycosylation on the secretion of hepatitis B virus virions and subviral particles: Role of the small envelope protein.

  2018cites this paper
• 25 – Hepatitis B Vaccines

  2018cites this paper
• Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus Therapy

  2018cites this paper
• Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity

  2017cites this paper
• Hepatitis B and D

  2017cites this paper
• HBV quasispecies composition in Lamivudine-failed chronic hepatitis B patients and its influence on virological response to Tenofovir-based rescue therapy

  2017cites this paper
• Chronologic changes in serum hepatitis B virus DNA, genotypes, surface antigen mutants and reverse transcriptase mutants during 25‐year nationwide immunization in Taiwan

  2017cites this paper
• Hepatitis B immune globulin and HBV-related liver transplantation.

  2016cites this paper
• Molecular Detection and Characterization of Hepatitis B Virus

  2016cites this paper
• Hepatitis B Recurrence: Major Milestones and Current Status

  2016cites this paper
• Organ Transplantation in HBV-Infected Patients

  2016cites this paper
• New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.

  2016cites this paper
• First description of past Hepatitis B Virus infection acute reactivation occurring in a Human Immunodeficiency Virus infected patient as manifestation of immune reconstitution inflammatory syndrome.

  2016cites this paper
• Serological and molecular analysis on the relationships between type 2 diabetes mellitus and hepatitis B virus infection.

  2016cites this paper
• Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission

  2016cites this paper
• Overview of hepatitis B viral replication and genetic variability.

  2016cites this paper
• Prophylactic managements of hepatitis B viral infection in liver transplantation.

  2016cites this paper
• Prevalence of mutations within major hydrophilic region of hepatitis B virus and their correlation with genotypes among chronically infected patients in Egypt.

  2016cites this paper
• Seroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia

  2015influential citation
• Management of chronic hepatitis B before and after liver transplantation.

  2015cites this paper
• Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation.

  2015cites this paper
• Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin

  2015cites this paper
• Hepatitis B Virus (HBV) and S-Escape Mutants: From the Beginning until Now

  2015cites this paper
• Prevention of Post-transplant HBV

  2015cites this paper
• Genomic Diversity of Hepatitis B Virus Infection Associated With Fulminant Hepatitis B Development

  2015cites this paper
• Reactivation of a hepatitis B virus surface-antigen mutant following an autologous stem-cell transplant for multiple myeloma in an anti-HBc-negative patient

  2015cites this paper
• Nucleoside–Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation

  2015cites this paper
• Risk factors for hepatitis B virus recurrence after living donor liver transplantation: A 17‐year experience at a single center

  2015cites this paper
• HBV Disease Spectrum and OBI

  2015cites this paper
• HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation

  2014cites this paper
• Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives

  2014cites this paper
• Spontaneous HBsAg loss in Korean patients: relevance of viral genotypes, S gene mutations, and covalently closed circular DNA copy numbers

  2014cites this paper
• Hepatitis B Virus and Hepatitis Delta Virus

  2014cites this paper
• Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications.

  2014cites this paper
• Immunopathogenesis of Chronic Hepatitis B and the Clinical Events That Shape its Natural History

  2014cites this paper
• Prevention of Hepatitis B Virus Reinfection in Liver Transplant Recipients

  2014cites this paper
• Molecular Epidemiology and Genotyping of Hepatitis B Virus of HBsAg-Positive Patients in Oman

  2014cites this paper
• Subgenotypes and Mutations in the S and Polymerase Genes of Hepatitis B Virus Carriers in the West Bank, Palestine

  2014cites this paper
• HBsAg variants: diagnostic-escape and diagnostic dilemma.

  2013cites this paper
• Performance Evaluation of Immunoassay Detection of HBsAg Mutants and Their Clinical Significance in the High Risk Groups

  2013cites this paper
• Mutational analysis of HBs Ag-positive mothers and their infected children despite immunoprophylaxis.

  2013cites this paper
• Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide study

  2013cites this paper
• Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach.

  2013cites this paper
• Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living‐donor liver transplantation

  2013cites this paper
• Prophylaxis of hepatitis B infection in solid organ transplant recipients

  2013cites this paper
• Prophylaxis for recurrent hepatitis B virus infection following liver transplantation

  2013cites this paper
• Problems of diagnosis of the hepatitis B virus

  2013cites this paper
• 15 – Hepatitis B vaccines

  2013cites this paper
• Chapter 9 – Transplantation for Hepatitis A and B

  2013cites this paper
• Management of Hepatitis B Virus Infection in Liver Transplant Recipients

  2013cites this paper
• Hepatitis B virus genetic variants: biological properties and clinical implications

  2013cites this paper
• Molecular Variants of Hepatitis B Surface Antigen (HBsAg)

  2013cites this paper
• Performance of hepatitis B surface antigen tests with the first WHO international hepatitis B virus genotype reference panel.

  2013cites this paper
• Analysis of S gene mutation of the hepatitis B virus in adult liver transplant recipients showing resistance to hepatitis B immunoglobulin therapy.

  2013cites this paper
• Naturally Occurring Hepatitis B Virus B-Cell and T-Cell Epitope Mutants in Hepatitis B Vaccinated Children

  2013cites this paper
• Hepatitis B virus surface antigen (HBsAg) mutations are rare but clustered in immune epitopes in chronic carriers from Sistan-Balouchestan Province, Iran.

  2013cites this paper
• Treatment of patients with HBV-related decompensated cirrhosis and liver transplanted patients.

  2013cites this paper
• The option of HBIG-free prophylaxis against recurrent HBV.

  2012cites this paper
• Evaluation of the Abbott HBV RUO Sequencing Assay Combined with Laboratory-Modified Interpretive Software

  2012cites this paper
• Variations in the S and P Regions of the Hepatitis B Virus Genome Under Immunosuppression In Vitro and In Vivo

  2012cites this paper
• Variabilité génétique du virus de l'hépatite B et implication sur le diagnostic et la pathogénèse

  2012cites this paper
• HBsAg Variants: Common Escape Issues

  2012cites this paper
• Management of Hepatitis B Virus Infection in Liver Transplantation Setting; The Rising Concerns and Growing Hopes, Report From 10th Congress of the Iranian Society for Organ Transplantation, 2011, Shiraz, Iran

  2012cites this paper
• Management of Patients with Chronic Hepatitis B Before and After Liver Transplantation: An Update

  2012cites this paper
• Antiviral drugs in the prophylaxis of HBV infection.

  2012cites this paper
• Mutations in the major hydrophilic region (MHR) of Hepatitis B virus genotype C in North China

  2012cites this paper
• Impaired Virion Secretion by Hepatitis B Virus Immune Escape Mutants and Its Rescue by Wild-Type Envelope Proteins or a Second-Site Mutation

  2012cites this paper
• Molecular Mechanisms Underlying Occult Hepatitis B Virus Infection

  2012cites this paper